Cargando…
Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets
Palliative chemotherapy is the mainstay of treatment of advanced gastric carcinoma (GC). Monoclonal antibodies including trastuzumab, ramucirumab, and pembrolizumab have been shown to provide additional benefits. However, the clinical outcomes are often unpredictable and they can vary widely among p...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874689/ https://www.ncbi.nlm.nih.gov/pubmed/29522457 http://dx.doi.org/10.3390/biomedicines6010032 |